drugset / Trial / NCT04669782

Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging

NCT04669782

Terminated 99 enrolled University of Milano Bicocca
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an interventional study on nutraceuticals. It is a randomized controlled, open-label, prospective, single-center study that involves the enrollment of 82 patients with osteoporosis and 41 subjects without osteoporosis. The hypothesis the decarboxylated form of Osteocalcin (OC), called GluOC, represents a clinically useful marker for monitoring the effects of supplementation with vitamin K in association with anabolic treatment with teriparatide will be analyzed not only on bone but also on skeletal muscle and energy metabolism in patients with severe osteoporosis.

Timeline

Start
2020-11-24
Primary completion
2024-07-04
Completion
2024-07-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Teriparatide Protein / enzyme biologic

Indications